De novo mutations in neurological and psychiatric disorders: effects, diagnosis and prevention
1 Center of Excellence in Neuroscience of the Université de Montréal , Quebec, Canada H2L 4MI
2 Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Quebec, Canada H2L 4MI
3 Department of Medicine, Université de Montréal, Quebec, Canada H2L 4MI
Genome Medicine 2012, 4:71 doi:10.1186/gm372Published: 25 September 2012
Neurological and psychiatric disorders account for a considerable proportion of the global disease burden. Although there is a high heritability and a significant genetic component in these disorders, the genetic cause of most cases has yet to be identified. Advances in DNA sequencing allowing the analysis of the whole human genome in a single experiment have led to an acceleration of the discovery of the genetic factors associated with human disease. Recent studies using these platforms have highlighted the important role of de novo mutations in neurological and psychiatric disorders. These findings have opened new avenues into the understanding of genetic disease mechanisms. These discoveries, combined with the increasing ease with which we can sequence the human genome, have important implications for diagnosis, prevention and treatment. Here, we present an overview of the recent discovery of de novo mutations using key examples of neurological and psychiatric disorders. We also discuss the impact of technological developments on diagnosis and prevention.